You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 27, 2024

Details for Patent: 10,729,653

✉ Email this page to a colleague

« Back to Dashboard

Which drugs does patent 10,729,653 protect, and when does it expire?

Patent 10,729,653 protects BRIVIACT and is included in one NDA.

This patent has twenty-seven patent family members in twenty-two countries.

Summary for Patent: 10,729,653

Title:	Pharmaceutical compositions comprising 2-oxo-1-pyrrolidine derivatives
Abstract:	The present invention relates to an immediate release formulation of pharmaceutical compounds.
Inventor(s):	Cuypers; Serge (Brussels, BE), Berwaer; Monique (Brussels, BE), Fanara; Domenico (Brussels, BE), Barillaro; Valery (Brussels, BE)
Assignee:	UCB BIOPHARMA SRL (Brussels, BE)
Application Number:	13/146,074
Patent Claim Types: see list of patent claims	Composition; Compound; Dosage form;

Drugs Protected by US Patent 10,729,653

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Ucb Inc	BRIVIACT	brivaracetam	TABLET;ORAL	205836-001	May 12, 2016		RX	Yes	No	⤷ Sign Up	⤷ Sign Up	Y				⤷ Sign Up
Ucb Inc	BRIVIACT	brivaracetam	TABLET;ORAL	205836-002	May 12, 2016		RX	Yes	No	⤷ Sign Up	⤷ Sign Up	Y				⤷ Sign Up
Ucb Inc	BRIVIACT	brivaracetam	TABLET;ORAL	205836-003	May 12, 2016		RX	Yes	No	⤷ Sign Up	⤷ Sign Up	Y				⤷ Sign Up
Ucb Inc	BRIVIACT	brivaracetam	TABLET;ORAL	205836-004	May 12, 2016		RX	Yes	No	⤷ Sign Up	⤷ Sign Up	Y				⤷ Sign Up
Ucb Inc	BRIVIACT	brivaracetam	TABLET;ORAL	205836-005	May 12, 2016		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 10,729,653

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
	09100083	Jan 29, 2009

PCT Information
PCT Filed	January 27, 2010	PCT Application Number:	PCT/EP2010/050892
PCT Publication Date:	August 26, 2010	PCT Publication Number:	WO2010/094535

International Family Members for US Patent 10,729,653

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
European Patent Office	2391349	⤷ Sign Up	C20160006 00188	Estonia	⤷ Sign Up
European Patent Office	2391349	⤷ Sign Up	C20160006	Estonia	⤷ Sign Up
Australia	2010215646	⤷ Sign Up
Brazil	PI1007161	⤷ Sign Up
Canada	2747395	⤷ Sign Up
China	102292071	⤷ Sign Up
China	104083328	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.